(Q114828977)
Statements
A phase I dose-escalation study of NKP-1339 in patients with advanced solid tumors refractory to treatment. (English)
N. R. Dickson
S. F. Jones
H. A. Burris
R. K. Ramanathan
G. J. Weiss
J. R. Infante
J. C. Bendell
W. McCulloch
D. D. Von Hoff
20 May 2011
15_suppl
2607-2607